Found: 20
Select item for more details and to access through your institution.
A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe.
- Published in:
- Journal of Patient-Reported Outcomes, 2020, v. 4, n. 1, p. 1, doi. 10.1186/s41687-020-00221-w
- By:
- Publication type:
- Article
Content validity of the Migraine-Specific Quality of Life Questionnaire version 2.1 electronic patient-reported outcome.
- Published in:
- Journal of Patient-Reported Outcomes, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1186/s41687-019-0138-x
- By:
- Publication type:
- Article
Efficacy of galcanezumab in patients with chronic migraine and a history of preventive treatment failure.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 2413, doi. 10.2147/PPA.S182563
- By:
- Publication type:
- Article
PP51 Strengths And Limitations Of Migraine Management Guidelines In The USA and Europe: A Targeted Literature Review.
- Published in:
- International Journal of Technology Assessment in Health Care, 2022, v. 38, p. S57, doi. 10.1017/S0266462322001908
- By:
- Publication type:
- Article
Patient Perspectives and Experiences of Preventive Treatments and Self-Injectable Devices for Migraine: A Focus Group Study.
- Published in:
- Patient, 2022, v. 15, n. 1, p. 93, doi. 10.1007/s40271-021-00525-z
- By:
- Publication type:
- Article
Trends in Depressed Mood and Suicidal Behaviors Among Female High School Students Who Engaged in Physical Fighting.
- Published in:
- Journal of Interpersonal Violence, 2021, v. 36, n. 9/10, p. NP4826, doi. 10.1177/0886260518790599
- By:
- Publication type:
- Article
Validation and meaningful within-patient change in work productivity and activity impairment questionnaire (WPAI) for episodic or chronic migraine.
- Published in:
- Journal of Patient-Reported Outcomes, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41687-023-00552-4
- By:
- Publication type:
- Article
Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2–4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER)
- Published in:
- Clinical Drug Investigation, 2022, v. 42, n. 3, p. 263, doi. 10.1007/s40261-021-01115-5
- By:
- Publication type:
- Article
Changes in migraine interictal burden following treatment with galcanezumab: Results from a phase III randomized, placebo‐controlled study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 5, p. 683, doi. 10.1111/head.14460
- By:
- Publication type:
- Article
Psychometric validation and meaningful within‐patient change of the Migraine‐Specific Quality of Life questionnaire version 2.1 electronic patient‐reported outcome in patients with episodic and chronic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 3, p. 511, doi. 10.1111/head.14031
- By:
- Publication type:
- Article
Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 10, p. 2304, doi. 10.1111/head.14013
- By:
- Publication type:
- Article
Measures of Functioning in Patients With Episodic Migraine: Findings From a Double‐Blind, Randomized, Placebo‐Controlled Phase 2b Trial With Galcanezumab.
- Published in:
- Headache: The Journal of Head & Face Pain, 2018, v. 58, n. 8, p. 1225, doi. 10.1111/head.13383
- By:
- Publication type:
- Article
A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns.
- Published in:
- Headache: The Journal of Head & Face Pain, 2017, v. 57, n. 10, p. 1532, doi. 10.1111/head.13202
- By:
- Publication type:
- Article
Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data.
- Published in:
- Headache: The Journal of Head & Face Pain, 2017, v. 57, n. 9, p. 1359, doi. 10.1111/head.13127
- By:
- Publication type:
- Article
Economics of Inhaled Oxygen Use as an Acute Therapy for Cluster Headache in the United States of America.
- Published in:
- Headache: The Journal of Head & Face Pain, 2017, v. 57, n. 9, p. 1416, doi. 10.1111/head.13167
- By:
- Publication type:
- Article
The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 4, p. 709, doi. 10.1007/s13300-023-01384-7
- By:
- Publication type:
- Article
Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 2, p. 455, doi. 10.1007/s11136-020-02632-0
- By:
- Publication type:
- Article